Search Tag: cardiac surgery

ICU Management

Cytosorbents-reports-steady-growth-in-q2-2015

2015 14 Aug

CytoSorbents Corporation, a critical care immunotherapy leader commercialising its CytoSorb® blood purification technology to reduce deadly uncontrolled inflammation in hospitalised patients around the world, reported financial and operational results for the three and six months ended June 30, 2015.  Recent Financial Highlights: Product revenues...Read more

Cardiology Management

Temperature-management-during-heart-surgery

2015 03 Aug

The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology have released clinical practice guidelines to address management of a patient’s temperature during open heart surgery. The guidelines appear in the August issue of  The Annals of Thoracic Surgery. Current strategies...Read more

Cardiology Management

Remote-ischaemic-preconditioning-reduces-kidney-injury-after-cardiac-surgery

2015 30 May

According to a study published in JAMA, the use of remote ischaemic preconditioning reduced the rate of kidney injury and the need for dialysis after cardiac surgery in high-risk patients. The study will be presented at the 52nd European Renal Association/European Dialysis and Transplant Association Congress. The procedure is performed to help protect...Read more

ICU Management

Post-operative-intubation-and-acute-kidney-injury

2014 09 Oct

Acute kidney injury (AKI) is a common complication after cardiac surgery and is generally associated with a poor prognosis. It is also an independent mortality factor in cardiac surgical patients. Cardiac surgery is typically performed under general anaesthesia with patients mechanically ventilated in the postoperative period until they have achieved...Read more

ICU Management

Esicm-2014-fenoldopam-after-cardiac-surgery-does-not-reduce-need-for-dialysis

2014 29 Sep

According to a study being presented at the European Society of Intensive Care Medicine (ESICM) annual congress in Barcelona, infusion of the antihypertensive agent fenoldopam in patients with acute kidney injury after cardiac surgery does not reduce the need for renal replacement therapy (dialysis) or risk of death at 30 days. The administration of...Read more

Cardiology Management

Blood-clot-vacuum-avoids-open-heart-surgery

2014 11 Jul

A catheter-based method for removing blood clots or other dangerous masses from cardiac blood vessels can save some patients from invasive heart surgery. The AngioVac system, a creation of AngioDynamics, is being used at the University of California San Diego’s Sulpizio Cardiovascular Center (SCVC), the first location in San Diego County to employ...Read more

Cardiology Management

Transcatheter-aortic-valve-implantation-for-failed-bioprostheses

2014 08 Jul

The one-year survival rate for patients who undergo transcatheter valve-in-valve implantation inside a malfunctioning bioprosthetic valve was 83.2 percent, according to a study by researchers at St. Paul’s Hospital in Vancouver, Canada. With bioprosthetic valves becoming more common than mechanical ones in surgical aortic valve replacement, an evaluation...Read more

Cardiology Management

Fcvb-2014-stem-cells-from-discarded-fat-protect-heart

2014 07 Jul

Patients undergoing cardiac surgery may need to have fat tissue removed for doctors to access the heart. Researchers have discovered that stem cells from the discarded mediastinal fat have protective properties when they are injected into the heart before the chest is closed at the end of surgery. The research results were presented at the biannual...Read more

Cardiology Management

Beta-blockers-no-improved-outcomes-for-heart-bypass-patients

2014 18 Jun

A new retrospective analysis of patient data suggests that the preoperative use of beta-blockers does not improve outcomes for all patients who undergo nonemergency coronary artery bypass grafting (CABG) surgery. Patients who had not experienced a heart attack in the three weeks prior to surgery, and who did not exhibit other high-risk symptoms, had...Read more

Cardiology Management

Postoperative-kidney-injury-less-likely-in-off-pump-heart-bypass-patients

2014 02 Jun

Patients requiring coronary artery bypass graft (CABG) operations may be less likely to incur acute postoperative kidney injuries when they are not put on a heart-lung machine (off-pump procedure). However, kidney function one year after surgery is not better preserved compared to on-pump patients. These findings are reported in JAMA’s June 4 issue...Read more

Cardiology Management

Leadless-pacemaker-promising-potential

2014 16 May

The world's first leadless pacemaker has demonstrated promising results as per a study conducted by Vivek Reddy, MD, Director of Arrhythmia Services for the Mount Sinai Hospital.   Twelve-month follow-up data with 32 bradycardia patients showed that the performance of the leadless pacemaker device was equivalent to those in traditional...Read more

Cardiology Management

Study-defibrillator-testing-prior-to-icd-procedure-unnecessary

2014 14 May

According to new research from McMaster University to be presented at the Heart Rhythm Society (HRS) in San Francisco this week, a commonly performed test conducted during certain types of cardiac surgery does not provide any assistance and may even be potentially harmful. The test in question is Defibrillator Testing (DT), conducted on patients...Read more

Cardiology Management

Golden-anniversary-for-life-saving-angioplasty

2014 16 Jan

Fifty years ago on January 16th a medical revolution occurred with the world’s first percutaneous transluminal angioplasty procedure. The procedure used a catheter to open a blockage from inside an artery, replacing the need to surgically open the vessel. This remarkable feat paved the way for minimally invasive vascular surgery and made angioplasty...Read more

Cardiology Management

Us-trial-of-edwards-sapien3-valve-to-begin

2014 15 Jan

Enrollment Completed in Trial of High-Risk Patients Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a single-arm, non-randomised clinical trial of...Read more